Patent · US Active

Controlled release delivery system for nasal application of neurotransmitters

US9801834B2 · kind B2 · utility

3Cited by

48References

10Claims

0Family size

Assignee

M et P Pharma AG · CH

Inventor

Claudia Mattern · Starnberg, DE

Key dates

Filing date	Oct 13, 2015
Grant date	Oct 31, 2017
Priority date	—
Expiry date	Oct 13, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to a galenical gel formulation for nasal administration of neurotransmitters/neuromodulators such as dopamine, serotonin or pregnenolone and progesterone. The special lipophilic or partly lipophilic system of the invention leads to high bioavailability of the active ingredient in plasma and brain caused by sustained serum levels and/or direct or partly direct transport from nose to the brain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.